Targeting Parkinson Disease “Pathway Abnormalities” With GT-02287: Jonas Hannestad, MD, PhD | NeurologyLive

Targeting Parkinson Disease “Pathway Abnormalities” With GT-02287: Jonas Hannestad, MD, PhD | NeurologyLive

WATCH TIME: 3 minutes | Captions are auto-generated and may contain errors.

“We know dopamine works really well, but beyond that, we don’t really fully understand how Parkinson works. There are many, what I call ‘pathway abnormalities’—things…

Continue Reading